Der er set uregelmæssig hjerterytme (atrieflimren) hos patienter, som har fået zoledronsyre mod postmenopausal osteoporose.
Irregular heart rhythm (atrial fibrillation) has been seen in patients receiving zoledronic acid for postmenopausal osteoporosis.